Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma. Aliagas E, Alay A, Martinez-Iniesta M, Hernandez-Madrigal M, et al. Br J Cancer 2021;125:1365-1376.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aliagas E, Alay A, Martinez-Iniesta M, Hernandez-Madrigal M, et al. Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma. Br J Cancer 2021;125:1365-1376.
PMID: 34588615